Trial Profile
A study comparing the stem cell mobilization efficacy of plerixafor plus G-CSF and cyclophosphamide plus G-CSF in patients with multiple myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jan 2016
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary) ; Cyclophosphamide
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- 11 Jan 2016 New trial record
- 04 Jan 2016 Results published in the Bone Marrow Transplantation